Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Haemonetics (HAE) Equity Ratio (2016 - 2025)

Historic Equity Ratio for Haemonetics (HAE) over the last 16 years, with Q4 2025 value amounting to 0.37.

  • Haemonetics' Equity Ratio rose 213.56% to 0.37 in Q4 2025 from the same period last year, while for Dec 2025 it was 0.37, marking a year-over-year increase of 213.56%. This contributed to the annual value of 0.33 for FY2025, which is 2340.14% down from last year.
  • Latest data reveals that Haemonetics reported Equity Ratio of 0.37 as of Q4 2025, which was up 213.56% from 0.35 recorded in Q3 2025.
  • In the past 5 years, Haemonetics' Equity Ratio registered a high of 0.44 during Q3 2023, and its lowest value of 0.33 during Q1 2025.
  • Over the past 5 years, Haemonetics' median Equity Ratio value was 0.39 (recorded in 2022), while the average stood at 0.39.
  • Per our database at Business Quant, Haemonetics' Equity Ratio crashed by 2686.53% in 2022 and then skyrocketed by 1367.71% in 2023.
  • Quarter analysis of 5 years shows Haemonetics' Equity Ratio stood at 0.39 in 2021, then grew by 6.56% to 0.41 in 2022, then increased by 3.76% to 0.43 in 2023, then decreased by 16.43% to 0.36 in 2024, then rose by 2.14% to 0.37 in 2025.
  • Its Equity Ratio was 0.37 in Q4 2025, compared to 0.35 in Q3 2025 and 0.36 in Q2 2025.